Slovakia Faces Critical Drug Shortages as Illegal Re-Exporting Soars
Table of Contents
A growing crisis in SlovakiaS pharmaceutical supply chain is leaving patients without essential medications, fueled by a lucrative-and often illegal-re-export market.
Slovakia is grappling with widespread drug shortages, a situation increasingly impacting access to vital treatments like antibiotics, insulin, vaccines, and medications for inflammatory conditions. The problem is compounded by the unauthorized export of medicines to neighboring countries, creating a precarious situation for patients across the nation.
European-Wide Problem Exacerbated by Re-Exporting
Drug shortages have been a pan-european concern since the onset of the pandemic, stemming from disruptions in manufacturing and supply chains. Though, a more insidious issue is gaining traction: the illegal re-export of pharmaceuticals. According to reports from TV Markíza,Slovakia has become a key hub for this activity.
“In Slovakia, re-export is a notable problem,” stated the chairman of the Slovak Chamber of Pharmacy, Ondrej Sukeľ. “We have facts from producers that 60-70 percent of the amount they import to Slovakia is exported.”
Price Discrepancies drive Illegal Trade
The root of the problem lies in Slovakia’s position as one of the countries with the lowest drug prices in Europe. This creates a significant financial incentive for re-exporters, who can purchase medications at lower costs and sell them abroad for ample profits. However, this practice directly impacts the availability of drugs for Slovak citizens.
While re-exporting is technically permitted under Slovak law, it is legally mandated that it not compromise the needs of domestic patients. In practice, this regulation is frequently violated. State inspectors discovered large-scale illegal exports in 17 pharmacies two years ago, and further cases have emerged since then. Pharmacies found in violation now face fines of up to 100,000 euros.
Government response and Proposed Reforms
Minister of Health Kamil Šaško acknowledges the severity of the issue and pledges a governmental response. “It is indeed in the process, it is actually happening for the first time,” Šaško stated. “We are in the process with,I suspect,28 pharmacies. Re-export is a problem. This will also be largely addressed by the upcoming amendment, which will soon enter the interdepartmental comment process.”
Experts emphasize the need for enhanced monitoring of the entire pharmaceutical supply chain, from manufacturers to distributors, pharmacies, hospitals, and ultimately, patients. “To control the entire flow of medicines… We already have such systems,” explained Jana Ježíková, an analyst and former
The proposed legislative changes aim to improve medicine availability and adjust pricing structures. The Ministry of Health anticipates initial results from these reforms as early as next spring. Untill then,patients and pharmacists remain in a state of uncertainty,frequently enough relying on personal connections and informal supply networks to secure necessary medications.
Expanded News Report:
Why is this happening? Slovakia is experiencing critical drug shortages due to a surge in illegal re-exporting of pharmaceuticals.The contry’s significantly lower drug prices compared to its European neighbors create a lucrative incentive for traders to purchase medications in Slovakia and sell them abroad for profit. This practice undermines the availability of essential medicines for Slovak citizens.
Who is affected? The crisis directly impacts Slovak patients who are struggling to access vital medications, including antibiotics, insulin, vaccines, and
